Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ESTOC: Suplatast Tosilate for Interstitial Cystitis
jRCTs051210106Completed
- Sponsor
- Nara Medical University
- Start
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of suplatast tosilate in Interstitial Cystitis-Bladder Pain Syndrome (IC/BPS) (2 arms), sponsored by Nara Medical University. Primary endpoint: Change in interstitial cystitis symptom score. Started Oct 2021; status: completed.
02
Drugs
suplatast tosilate
03
Conditions
Interstitial Cystitis-Bladder Pain Syndrome (IC/BPS)
Beyond the preview
Go deeper on jRCTs051210106.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051210106.